Bioadaptives, Inc. (BDPT) Gross Profit (2016 - 2026)

Bioadaptives (BDPT) posted Gross Profit of $4113.0 for Q1 2026, down 45.76% sequentially from $7583.0 in Q4 2025.

Bioadaptives, Inc. (BDPT) Gross Profit (2016 - 2026) Analysis & Trends

Bioadaptives has reported Gross Profit for 9 years, with the latest figure at $4113.0 in Q1 2026.

Quarterly Gross Profit changed N/A year-over-year to $4113.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16610.0 (up 3771.79% YoY) and the FY2025 annual result came in at $12497.0, up 210.1% from the prior year.
Gross Profit slipped to $4113.0 in Q1 2026 per BDPT's latest filing, from $7583.0 in the prior quarter.
Over five years, Gross Profit peaked at $7583.0 in Q4 2025 and troughed at $429.0 in Q2 2024.
A 5-year average of $2756.1 and a median of $2076.5 in 2022 frame the typical range for Gross Profit.
The sharpest annual moves came in 2023 and 2024: Gross Profit jumped 162.04% in 2023, then tumbled 71.21% in 2024.
Over 5 years, Gross Profit stood at $1030.0 in 2022, then soared by 162.04% to $2699.0 in 2023, then slumped by 84.11% to $429.0 in 2024, then surged by 1667.6% to $7583.0 in 2025, then sank by 45.76% to $4113.0 in 2026.
According to Business Quant data, Gross Profit over the past three periods registered $4113.0, $7583.0, and $3851.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Download Data